Synexus Executive and Leadership Team

Lucia Smigel, the Chief Executive Officer at Synexus, directs the overarching corporate strategy and operational framework. Overseeing global site and patient services, Smigel ensures the efficient execution of clinical trial planning and patient enrollment initiatives. This leadership role involves driving innovation in service delivery to accelerate medical research timelines. By optimizing resource allocation and fostering cross-functional collaboration, Lucia Smigel directly impacts the company's ability to meet client demands and expand market reach. The focus remains on enhancing the quality and speed of clinical trial processes, solidifying Synexus's position as a leader in the research support sector.

O.P.Y. Liang, the Group Chief Executive Officer at Synexus, spearheads the strategic direction and expansion of the organization across its global operations. Liang's purview encompasses the integration of site and patient services, ensuring seamless trial planning and patient enrollment processes worldwide. This executive function involves cultivating strategic partnerships and identifying new market opportunities to enhance Synexus's international presence. By driving operational excellence and fostering a culture of continuous improvement, O.P.Y. Liang significantly contributes to the company's growth trajectory. The objective is to elevate Synexus's capabilities in supporting complex clinical trials, thereby advancing global health outcomes.

Tyler Hagl, the Founder & Chief Executive Officer at Synexus, established the company's foundational mission and continues to guide its strategic vision. Hagl's leadership focuses on the core services of site and patient support for clinical trials, emphasizing patient enrollment and global coverage. This role involves setting the standard for operational efficiency and innovation within the research services sector. By championing the company's commitment to accelerating medical discoveries, Tyler Hagl ensures Synexus remains at the forefront of clinical trial support. The founder's ongoing influence drives the organization's dedication to providing comprehensive solutions that benefit both researchers and patients.

Craig Smith, the Chief Financial Officer at Synexus, manages the company's financial health and strategic fiscal planning. Smith oversees all financial operations, including budgeting, forecasting, and resource allocation for site and patient services. This critical function ensures the financial viability and sustainable growth of Synexus's global trial planning and patient enrollment initiatives. By implementing robust financial controls and driving cost-efficiency measures, Craig Smith directly supports the company's mission to accelerate clinical research. The CFO's expertise is vital in navigating the financial complexities of the biopharmaceutical services industry and maximizing shareholder value.